SCHEMBL4468038

SCHEMBL4468038

CN(C)C1CN(c2ccccc2)CC[N]1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.39
CHRNA7 P36544 3/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
CHRNB2 P17787 1/20 0.37
NFKB1 P19838 1/20 0.37
MAPK1 P28482 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA4 P43681 1/20 0.37
HSD17B10 Q99714 1/20 0.37
DRD2 P14416 2/20 0.36
DRD3 P35462 1/20 0.36
SIGMAR1 Q99720 4/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
APOBEC3A P31941 1/20 0.36
PMP22 Q01453 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2172883 0.80 NOTUM (0.41) NOTUMALOX15MAPK1HSD17B10LMNA
SCHEMBL2422800 0.79 NOTUM (0.40) NOTUMMAPK1MEN1KMT2AMAPT
SCHEMBL6526654 0.74 NOTUM (0.42) NOTUMCHRNA7CYP3A4ALOX15CHRNB2
SCHEMBL2094438 0.72 MAPK1 (0.45) NOTUMCHRNA7CYP3A4ALOX15CHRNB2
SCHEMBL9046550 0.71 SLC2A1 (0.40) CHRNA7ALOX15HSD17B10DRD2DRD3
SCHEMBL2172788 0.71 ADAM10 (0.43) NOTUMCYP3A4MAPK1HSD17B10LMNA
SCHEMBL16719407 0.70 MCHR1 (0.56) NOTUMDRD2HTR3AMBTD1L3MBTL3
SCHEMBL13174962 0.70 MCHR1 (0.56) NOTUMDRD2HTR3AMBTD1L3MBTL3
SCHEMBL27752850 0.70 MCHR1 (0.56) NOTUMDRD2HTR3AMBTD1L3MBTL3
SCHEMBL2176945 0.70 L3MBTL3 (0.45) NOTUMCHRNA7CYP3A4ALOX15CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853243-B2 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases INCYTE CORPORATION (US) 2014-10-07 US disclosed
US-7491724-B2 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases INCYTE CORPORATION (US) 2009-02-17 US disclosed
US-4148895-A HYPOTENSIVE, ANTIARRHYMIA AGENTS HOECHST AKTIENGESELLSCHAFT (DE) 1979-04-10 US disclosed